Chargement en cours...
Lupus anticoagulant and mortality in patients hospitalized for COVID-19
Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant profile of COVID-19. However, the association betwe...
Enregistré dans:
| Publié dans: | J Thromb Thrombolysis |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648549/ https://ncbi.nlm.nih.gov/pubmed/33159639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-020-02335-w |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|